Systemic estrogen for menopause comes in three main forms: oral pills, transdermal patches, and gels or sprays. All three can ease hot flashes, night sweats, and other menopause symptoms effectively. The biggest practical difference is the route: patches, gels, and sprays are absorbed through the skin and skip the liver's "first-pass" processing, a route that observational research links to a lower blood-clot risk than swallowing a pill. For many women the right choice comes down to health history, convenience, skin tolerance, and cost.
How each route is used
All three deliver estrogen into the bloodstream to treat symptoms body-wide — different from low-dose vaginal estrogen, which targets only vaginal dryness and is a separate decision. Oral pills are swallowed once daily and are often combined with a progestogen in a single tablet. Patches are adhesive squares worn on the lower abdomen or buttock and changed once or twice a week, releasing estrogen steadily. Gels and sprays are measured onto the skin — often the arm or thigh — once daily and left to dry before dressing.
The transdermal-versus-oral clot-risk signal
When you swallow an estrogen pill, it passes through the liver before reaching the rest of the body. This "first-pass" metabolism nudges up certain clotting factors, which is why oral estrogen carries a higher venous-thromboembolism (VTE, or blood-clot) signal in studies. Estrogen absorbed through the skin bypasses that first liver pass, and observational data link transdermal routes to little or no increase in clot risk. National guidance shaping how HRT is prescribed, including NICE and the NHS, reflects this: people with clot risk factors are often steered toward a patch, gel, or spray.
It helps to frame this as a signal that informs an individual decision — not proof that transdermal HRT is "safe for everyone." Baseline risk, personal and family history, and other health conditions all matter, and only your clinician can weigh them together.
Where progesterone fits
If you still have a uterus, systemic estrogen is paired with a progestogen — frequently micronized progesterone — to protect the uterine lining, whatever the estrogen route. That's the difference between estrogen-only and combined HRT. Progesterone comes as its own capsule or is built into some combined patches and pills. To understand how these hormones work together, see estrogen vs. progesterone and progesterone for menopause.
| Route | How it's used | Blood-clot risk consideration | Pros | Cons | Tends to suit |
|---|---|---|---|---|---|
| Oral pill | Swallowed once daily; often a single tablet combining estrogen and a progestogen. | Passes through the liver first (first-pass metabolism), which raises some clotting factors and is associated with a higher VTE signal than skin routes. | Simple, familiar, widely available, often low-cost; no skin site to manage. | Higher observed clot and stroke signal; absorption depends on gut and liver; daily dosing. | People at low baseline clot risk who prefer a simple daily tablet. |
| Transdermal patch | Adhesive patch worn on the lower abdomen or buttock, changed once or twice weekly. | Absorbed through the skin, bypassing first-pass liver metabolism; observational data link it to little or no increase in clot risk. | Steady hormone levels; only one or two changes a week; lower clot signal; useful if pills upset digestion. | Skin irritation or itching at the site; can loosen with heat, sweat, or swimming; visible on skin. | People with clot risk factors, migraine, or a higher BMI, or who prefer not to dose daily. |
| Gel or spray | A measured pump of gel or metered spray applied to the skin daily and left to dry. | Also transdermal, so it bypasses first-pass metabolism and shares the lower clot-risk signal of skin routes. | Flexible dose adjustment; no adhesive; discreet once dry; lower clot signal. | Daily application; must avoid skin-to-skin transfer to others until dry; can wash or sweat off. | People who want transdermal benefits without a patch, or who react to adhesives. |
Skin reactions, convenience, and cost
Patches can cause redness or itching where they stick, and heat, sweat, or swimming can loosen them; rotating the site helps. Gels and sprays avoid adhesive but need drying time and care not to transfer to others through close skin contact until dry. Pills sidestep skin issues entirely but rely on daily dosing and on gut and liver absorption. Cost and availability vary by product, insurance, and region — sometimes a generic pill is cheapest, while some transdermal products cost more. If cost is a concern, it is worth asking about generic options.
Who each route tends to suit
There is no single "best" HRT — the routes are broadly comparable for symptom relief, so preference plays a big role. Pills tend to suit people at low baseline clot risk who like a simple daily tablet. Patches tend to suit those who prefer twice-weekly dosing or who have clot risk factors, migraine, or a higher BMI. Gels and sprays tend to suit people who want transdermal benefits with flexible daily dosing and no adhesive. Not sure where you are in the transition? The menopause stage quiz can help you frame the conversation. You can also read about bioidentical hormones and browse the menopause hub for related guidance.
Talk to your clinician
The route that fits you depends on your clot and cardiovascular history, symptoms like hot flashes, skin tolerance, and cost — factors best weighed one-on-one. This article is educational and is not a recommendation to start, stop, or switch any medication. Talk to your clinician about which form of HRT, if any, is right for you.